Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
Sign Up to like & getrecommendations! Published in 2023 at "Pharmaceuticals"
DOI: 10.3390/ph16020227
Abstract: Despite recent advances in multimodality therapy for glioblastoma (GB) incorporating surgery, radiotherapy, chemotherapy and targeted therapy, the overall prognosis remains poor. One of the interesting targets for GB therapy is the histone deacetylase family (HDAC).… read more here.
Keywords: radiopharmaceuticals glioblastoma; introducing hdac; therapy; hdac targeting ... See more keywords